Also, by increasing our understanding of the role played by ECM components in the tumor microenvironment and their potential impact on protease inhibition, we can provide more reliable data for further assays searching for CTSB inhibitors in cancer tumors. The gene discussed is CTSB; the disease is neoplasm.